Related references
Note: Only part of the references are listed.Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
Janelle Drouin-Ouellet et al.
ANNALS OF NEUROLOGY (2015)
The role of tau in the pathological process and clinical expression of Huntington's disease
Romina Vuono et al.
BRAIN (2015)
Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease
Marta Fernandez-Nogales et al.
HUMAN MOLECULAR GENETICS (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease
M. Valenza et al.
CELL DEATH AND DIFFERENTIATION (2015)
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
J. J. Credle et al.
CELL DEATH AND DIFFERENTIATION (2015)
Mutant huntingtin alters Tau phosphorylation and subcellular distribution
David Blum et al.
HUMAN MOLECULAR GENETICS (2015)
Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease
Maud Gratuze et al.
HUMAN MOLECULAR GENETICS (2015)
Mutant Huntingtin is Present in Neuronal Grafts in Huntington Disease Patients
Francesca Cicchetti et al.
ANNALS OF NEUROLOGY (2014)
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain
Nastasia K. H. Lim et al.
HUMAN MOLECULAR GENETICS (2014)
Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned?
Lisa Scheuing et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Huntington's disease is a four-repeat tauopathy with tau nuclear rods
Marta Fernandez-Nogales et al.
NATURE MEDICINE (2014)
Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair
Bianca Marchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease
Han-Yun Hsiao et al.
HUMAN MOLECULAR GENETICS (2013)
Aging-Induced Nrf2-ARE Pathway Disruption in the Subventricular Zone Drives Neurogenic Impairment in Parkinsonian Mice via PI3K-Wnt/β-Catenin Dysregulation
Francesca L'Episcopo et al.
JOURNAL OF NEUROSCIENCE (2013)
Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes
Hong-Mei Wang et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases
Valeriy Duka et al.
PLOS ONE (2013)
Wnt your brain be inflamed? Yes, it Wnt!
Bianca Marchetti et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization
Haruyuki Hongo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons
Francois-Xavier Lejeune et al.
BMC GENOMICS (2012)
Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/β-Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair
Francesca L'Episcopo et al.
JOURNAL OF NEUROSCIENCE (2012)
Reagents that block neuronal death from Huntington's disease also curb oxidative stress
Antonio Valencia et al.
NEUROREPORT (2012)
Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease
Mark I. Ransome et al.
NEURAL PLASTICITY (2012)
Changed Relative to What? Housekeeping Genes and Normalization Strategies in Human Brain Gene Expression Studies
Elizabeth M. Tunbridge et al.
BIOLOGICAL PSYCHIATRY (2011)
Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs
Clare L. van Eyk et al.
HUMAN MOLECULAR GENETICS (2011)
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
Ulziibat Shirendeb et al.
HUMAN MOLECULAR GENETICS (2011)
Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
F. L'Episcopo et al.
NEUROBIOLOGY OF DISEASE (2011)
Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice
Francesca L'Episcopo et al.
REJUVENATION RESEARCH (2011)
Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture
C. J. Garwood et al.
CELL DEATH & DISEASE (2011)
GSK-3: functional insights from cell biology and animal models
Oksana Kaidanovich-Beilin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease
Francesca L'Episcopo et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects
Mathilde Faideau et al.
HUMAN MOLECULAR GENETICS (2010)
Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice
Jennifer Bradford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mutant Huntingtin and Glycogen Synthase Kinase 3-beta Accumulate in Neuronal Lipid Rafts of a Presymptomatic Knock-In Mouse Model of Huntington's Disease
Antonio Valencia et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
Eleonore Beurel et al.
TRENDS IN IMMUNOLOGY (2010)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain
Eleonore Beurel et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
Agnes Petit-Paitel et al.
PLOS ONE (2009)
Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms
Jennifer Bradford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Patient and caregiver quality of life in Huntington's disease
Rebecca E. Ready et al.
MOVEMENT DISORDERS (2008)
Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
K. Leroy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation
Pamela A. Lochhead et al.
MOLECULAR CELL (2006)
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges et al.
HUMAN MOLECULAR GENETICS (2006)
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
JY Shin et al.
JOURNAL OF CELL BIOLOGY (2005)
Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway
Z Berger et al.
HUMAN MOLECULAR GENETICS (2005)
Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain
XH Li et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease
VV Senatorov et al.
MOLECULAR PSYCHIATRY (2004)
Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)
F Gennuso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets
CL Andersen et al.
CANCER RESEARCH (2004)
Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event
A Cole et al.
BIOCHEMICAL JOURNAL (2004)
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation
XD Chen et al.
FASEB JOURNAL (2004)
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418
R Bhat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evidence for more widespread cerebral pathology in early HD - An MRI-based morphometric analysis
HD Rosas et al.
NEUROLOGY (2003)
Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation
J Carmichael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Loss of normal huntingtin function: new developments in Huntington's disease research
E Cattaneo et al.
TRENDS IN NEUROSCIENCES (2001)
Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
JJ Lucas et al.
EMBO JOURNAL (2001)
Share Paper
